Financial incentives for smoking cessation in low-income smokers: study protocol for a randomized controlled trial

被引:14
|
作者
Etter, Jean-Francois [1 ]
机构
[1] Univ Geneva, Fac Med, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland
关键词
Financial incentives; Smoking; Smoking cessation; CONTINGENCY MANAGEMENT; COST-EFFECTIVENESS; CIGARETTE-SMOKING; NICOTINE REPLACEMENT; CARBON-MONOXIDE; SALIVA COTININE; ABSTINENCE; REINFORCEMENT; VALIDATION; THERAPY;
D O I
10.1186/1745-6215-13-88
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Tobacco smoking is the leading avoidable cause of death in high-income countries. The smoking-related disease burden is borne primarily by the least educated and least affluent groups. Thus, there is a need for effective smoking cessation interventions that reach to, and are effective in this group. Research suggests that modest financial incentives are not very effective in helping smokers quit. What is not known is whether large financial incentives can enhance longer-term (1 year) smoking cessation rates, outside clinical and workplace settings. Trial design: A randomized, parallel groups, controlled trial. Methods: Participants: Eight hundred low-income smokers in Switzerland (the less affluent third of the population, based on fiscal taxation). Intervention: A smoking cessation program including: (a) financial incentives given during 6 months; and (b) Internet-based counseling. Financial rewards will be offered for biochemically verified smoking abstinence after 1, 2, and 3 weeks and 1, 3, and 6 months, for a maximum of 1,500 CHF (1,250 EUR, 1,500 USD) for those abstinent at all time-points. All participants, including controls, will receive Internet-based, individually-tailored, smoking cessation counseling and self-help booklets, but there will be no in-person or telephone counseling, and participants will not receive medications. The control group will not receive financial incentives. Objective: To increase smoking cessation rates. Outcome: Smoking abstinence after 6 and 18 months, not contradicted by biochemical tests. We will assess relapse after the end of the intervention, to test whether 6-month effects translate into sustained abstinence 12 months after the incentives are withdrawn. Randomization: Will be done using sealed envelopes drawn by participants. Blinding: Is not possible in this context. Discussion: Smoking prevention policies and interventions have been least effective in the least educated, low-income groups. Combining financial incentives and Internet-based counseling is an innovative approach that, if proven acceptable and effective, could be later implemented on a large scale at a reasonable cost, decrease health disparities, and save many lives.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] EFFECTS OF A TELEVISED SMOKING CESSATION INTERVENTION AMONG LOW-INCOME AND MINORITY SMOKERS
    JASON, LA
    TAIT, E
    GOODMAN, D
    BUCKENBERGER, L
    GRUDER, CL
    AMERICAN JOURNAL OF COMMUNITY PSYCHOLOGY, 1988, 16 (06) : 863 - 876
  • [42] Smoking Cessation Programs Are Less Effective in Smokers with Low Socioeconomic Status Even When Financial Incentives for Quitting Smoking Are Offered-A Community-Randomized Smoking Cessation Trial in Denmark
    Pisinger, Charlotta
    Toxvaerd, Cecilie Goltermann
    Rasmussen, Mette
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (17)
  • [43] Brief advice and active referral for smoking cessation services among community smokers: a study protocol for randomized controlled trial
    Suen, Yi Nam
    Wang, Man Ping
    Li, William Ho Cheung
    Kwong, Antonio Cho Shing
    Lai, Vienna Wai Yin
    Chan, Sophia Siu Chee
    Lam, Tai Hing
    BMC PUBLIC HEALTH, 2016, 16
  • [44] Brief advice and active referral for smoking cessation services among community smokers: a study protocol for randomized controlled trial
    Yi Nam Suen
    Man Ping Wang
    William Ho Cheung Li
    Antonio Cho Shing Kwong
    Vienna Wai Yin Lai
    Sophia Siu Chee Chan
    Tai Hing Lam
    BMC Public Health, 16
  • [45] The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial
    Sinclair, Lesley
    McFadden, Margaret
    Tilbrook, Helen
    Mitchell, Alex
    Keding, Ada
    Watson, Judith
    Bauld, Linda
    Kee, Frank
    Torgerson, David
    Hewitt, Catherine
    McKell, Jennifer
    Hoddinott, Pat
    Harris, Fiona M.
    Uny, Isabelle
    Boyd, Kathleen
    McMeekin, Nicola
    Ussher, Michael
    Tappin, David M.
    TRIALS, 2020, 21 (01)
  • [46] A Randomized Trial to Address Food Insecurity and Promote Smoking Cessation Among Low-Income Adults
    Kim-Mozeleski, Jin E.
    Castele, Madeline C.
    Nambiar, Pooja
    Chagin, Kevin M.
    Pike Moore, Stephanie
    Hardy, Patricia
    Cook, Karen
    Sehgal, Ashwini R.
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2024, 15
  • [47] The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial
    Lesley Sinclair
    Margaret McFadden
    Helen Tilbrook
    Alex Mitchell
    Ada Keding
    Judith Watson
    Linda Bauld
    Frank Kee
    David Torgerson
    Catherine Hewitt
    Jennifer McKell
    Pat Hoddinott
    Fiona M. Harris
    Isabelle Uny
    Kathleen Boyd
    Nicola McMeekin
    Michael Ussher
    David M. Tappin
    Trials, 21
  • [48] Specialized tobacco quitline and basic needs navigation interventions to increase cessation among low income smokers: Study protocol for a randomized controlled trial
    McQueen, Amy
    Roberts, Christina
    Garg, Rachel
    Caburnay, Charlene
    Fu, Qiang
    Gordon, Jacob
    Bush, Terry
    Pokojski, Robin
    Thompson, Tess
    Kreuter, Matthew
    CONTEMPORARY CLINICAL TRIALS, 2019, 80 : 40 - 47
  • [49] Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
    Janina Lüscher
    Corina Berli
    Philipp Schwaninger
    Urte Scholz
    BMC Public Health, 19
  • [50] Smoking cessation with smartphone applications (SWAPP): study protocol for a randomized controlled trial
    Luscher, Janina
    Berli, Corina
    Schwaninger, Philipp
    Scholz, Urte
    BMC PUBLIC HEALTH, 2019, 19 (01)